Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC). 1998

J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
Department of Med. Oncology, University Hospital VU, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D003842 Deoxycytidine Kinase An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74. Kinase, Deoxycytidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000093542 Gemcitabine A deoxycytidine antimetabolite used as an antineoplastic agent. 2',2'-Difluoro-2'-Deoxycytidine,2',2'-Difluorodeoxycytidine,2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate,2'-Deoxy-2'-Difluorocytidine,Gemcitabine Hydrochloride,Gemcitabine, (D-threo-pentafuranosyl)-Isomer,Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer,Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer,Gemicitabine,2',2'-DFDC,Gemzar,LY 188011,LY-188011,dFdCyd,188011, LY,2' Deoxy 2' Difluorocytidine,2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate,Hydrochloride, Gemcitabine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
January 1998, Advances in experimental medicine and biology,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
January 1998, Advances in experimental medicine and biology,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
January 1993, Advances in enzyme regulation,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
August 1999, Nucleosides & nucleotides,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
September 2015, Oncotarget,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
July 1990, Cancer research,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
January 2001, Nucleosides, nucleotides & nucleic acids,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
November 2003, Clinical and experimental medicine,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
November 2016, International journal of molecular sciences,
J R Kroep, and C J van Moorsel, and G Veerman, and D A Voorn, and R M Schultz, and J F Worzalla, and L R Tanzer, and R L Merriman, and H M Pinedo, and G J Peters
May 1993, Biochemical pharmacology,
Copied contents to your clipboard!